868528-95-4

Basic information

• Product Name: 4-(N,N-bis(tert-butoxycarbonyl)amino)cyclohexanone
• Synonyms: 4-(N,N-bis(tert-butoxycarbonyl)amino)cyclohexanone
• CAS NO: 868528-95-4
• Molecular Formula: C₁₆H₂₇NO₅
• Molecular Weight: 313.38928
• Mol File: 868528-95-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(N,N-bis(tert-butoxycarbonyl)amino)cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(N,N-bis(tert-butoxycarbonyl)amino)cyclohexanone(868528-95-4)
• EPA Substance Registry System: 4-(N,N-bis(tert-butoxycarbonyl)amino)cyclohexanone(868528-95-4)

Safety Data

• Hazardous Substances Data: 868528-95-4(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 179321-49-4 N-(tert-butoxycarbonyl)-4-aminocyclohexanone 

Downstream Products

• 868528-90-9 (2R,4S)-4-(N,N-bis(tert-butoxycarbonyl)amino)-2-(6-chloropyridin-3-yl)cyclohexanone 
• 868528-89-6 (1S,2R,4S)-methanesulfonic acid 4-amino-2-(6-chloropyridin-3-yl)cyclohexyl ester 
• 140111-52-0 epibatidine 
• 868528-88-5 (1S,2R,4S)-methanesulfonic acid 4-(N,N-bis(tert-butoxycarbonyl)amino)-2-(6-chloropyridin-3-yl)cyclohexyl ester 
• 868528-87-4 (1S,2R,4S)-4-(N,N-bis(tert-butoxycarbonyl)amino)-2-(6-chloropyridin-3-yl)cyclohexanol 

Relevant articles and documents

3-(dimethylaminomethyl) cyclohex-4-alcohol derivative as well as preparation method and pharmaceutical application thereof

The invention belongs to the field of pharmacy, and relates to a 3-(dimethylaminomethyl) cyclohex-4-alcohol derivative with a general formula (I) or a salt thereof and a preparation method, and relates to an application of the compound in treatment of opioid receptor mediated diseases. The present invention provides a pharmaceutically acceptable solvate or hydrate of a compound of formula (I), and also provides a pharmaceutical composition comprising: a compound of formula (I) or a pharmaceutically acceptable salt, solvate or hydrate thereof; and a pharmaceutically acceptable carrier. The medicine prepared from the compound can be used for treating or improving diseases related to an opioid receptor; wherein the diseases can be selected from but not limited to pain, gastrointestinal diseases and depression.